Viewing Study NCT06529367


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-01-04 @ 7:00 PM
Study NCT ID: NCT06529367
Status: RECRUITING
Last Update Posted: 2024-08-01
First Post: 2024-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing a Home Vision Self-Assessment Test to Office-Based Snellen Visual Acuity in Myopic Children
Sponsor: South Valley University
Organization:

Study Overview

Official Title: Comparing a Home Vision Self-Assessment Test to Office-Based Snellen Visual Acuity in Myopic Children
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to compare a home vision self-assessment test to office-based Snellen visual acuity in myopic children.
Detailed Description: Visual impairment is an important public health issue worldwide, with a heavy socioeconomic burden. More than 400 million people globally have mild to severe visual impairment.

Visual acuity (VA) screening is the most basic part of ophthalmic examination. Home vision screening tests have become an important way to obtain a measure of an individual's VA without an office-based clinic visit. Knowing a patient's VA can help ophthalmologists remotely triage acute calls, monitor visual recovery after medical or surgical interventions, and ensure visual stability in follow-up telemedicine visits.

Home vision screening tests have become an important way to obtain a measure of an individual's VA without an office-based clinic visit. Numerous electronic home vision assessment tools exist, but many of these are used through applications on mobile or tablet devices.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: